作者：
Jan-Alexis,Tremblay [1]
;
Florian,Peron [2]
;
Louis,Kreitmann [3]
;
Julien,Textoris [3]
;
Karen,Brengel-Pesce [3]
;
Anne-Claire,Lukaszewicz [3]
;
Laurence,Quemeneur [3]
;
Christophe,Vedrine [4]
;
Lionel K,Tan [5]
;
Fabienne,Venet [6]
;
Thomas,Rimmele [7]
;
Guillaume,Monneret [8]
;
REALISM study group [9]
作者单位：
EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Joint Research Unit HCL-bioMérieux, Herriot Hospital, 5 place d'Arsonval, 69003, Lyon, France. janalexis.tremblay@gmail.com.
[1]
Critical Care Service, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montréal, H1T2M4, Canada. janalexis.tremblay@gmail.com.
[2]
EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon - bioMérieux), Joint Research Unit HCL-bioMérieux, Herriot Hospital, 5 place d'Arsonval, 69003, Lyon, France.
[3]
Anesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, 69437, Lyon, France.
[4]
Sanofi Pasteur, Sanofi 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France.
[5]
BIOASTER, 40 Avenue Tony Garnier, 69007, Lyon, France.
[6]
GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
[7]
Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, 69437, Lyon, France.
[8]
Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Team 'NLRP3 Inflammation and Immune Response to Sepsis', Université Claude Bernard-Lyon 1, Lyon, France.
[9]
DOI
10.1186/s13613-022-01051-3
PMID
35976460
发布时间
2022-08-30
换一批
换一批
